Ozempic and Wegovy both contain the same active ingredient, semaglutide, but they serve different purposes: Wegovy is specifically approved for weight management in adults and children over 12 with obesity, and for those who are overweight with related health conditions such as high blood pressure, type 2 diabetes, or high cholesterol
Medications will only be prescribed by a licensed clinician if deemed medically appropriate after a thorough consultation
(Biomed Res Int 2015): modulacin de 4,000+ genes en queratinocitos humanos
Similarly, Okabe et al
2 10 Treatment of Blood Clots & Thrombosis In a thromboembolic emergency, thrombolytic agents that promote fibrinolysis are often used, sometimes in conjunction with a medical ultrasound technique called sonothrombolysis
Sources SingleCare: Mounjaro nausea: 7 Ways to find relief NIH: Tirzepatide-Induced Gastrointestinal Manifestations: A Systematic Review and Meta-Analysis The New England Journal of Medicine: Tirzepatide Once Weekly for the Treatment of Obesity GoodRx: 3 Tips to Cope With Nausea When Taking Tirzepatide (Mounjaro, Zepbound) GoodRx: 18 Tirzepatide (Mounjaro, Zepbound) Side Effects And How to Manage Them Drugs.com: Tirzepatide and Nausea: What Users Say FDA Label: MOUNJARO (Tirzepatide Injection) Medication Guide FDA Label: ZEPBOUND (Tirzepatide Injection) Medication Guide Important Medical Information and Disclaimers Important Current Status Update : On March 19, 2025, the FDA ended enforcement discretion for compounded tirzepatide